You Won't Believe How Much Money Berkshire Hathaway Gets From Moody's Dividends

Berkshire Hathaway holds almost 25 million Moody's shares (3.6% of its portfolio) worth about $11 billion; the original cost basis was $248 million (≈4,400% gain). Moody's pays an annual dividend of $4.12 (current yield ~0.85%), but Berkshire's yield on cost is ~41.2%; Berkshire received $93 million in Moody's dividends in 2025. The piece frames Moody's as a durable, dividend-generating moat stock within Buffett-style portfolios, though it is not on Motley Fool's current top-10 buy list.

Analysis

Moody’s sits squarely in the “financial infrastructure” bucket where pricing power and regulatory stickiness compound returns over long horizons. Beyond the headline dividend narrative, the more material driver is recurring analytics and surveillance revenue that grows faster than issuance in down cycles because clients pay for risk models, surveillance and legal defensibility — that’s what sustains margins when primary issuance dips.

Second-order effects: rising, predictable cash returns (dividends or buybacks) broaden the buyer base to liability-matched investors (insurers, pensions), which can compress realized volatility and support a higher valuation multiple over multi-year windows. But that same concentration of long-term holders reduces float and can exaggerate price moves on liquidity shocks, increasing event risk in short-dated option expiries.

Key risks are regulatory and legal regime shifts and faster-than-expected AI-driven disintermediation. Regulation or major litigation can knock multiples by 20–30% inside quarters; conversely, incremental data products or benchmark adoption could accelerate organic revenue growth by mid-teens over 2–3 years. Disruption by AI is plausible but slow because ratings are embedded in contracts and regulatory frameworks — expect measured, multi-year erosion rather than sudden obsolescence.

Near-term catalysts that would re-rate the security: continued margin expansion in analytics, a large buyback announcement, or conservative regulatory guidance being replaced by business-friendly rules. Monitor issuance calendars, regulatory comment deadlines, and option-implied skew for cheap tail hedges as primary triggers to add/trim exposure.

Key Decisions for Investors

• Long MCO (1.0–1.5% portfolio) via Jan-2028 LEAP calls (delta ~0.45–0.6) — 1–3 year horizon. Rationale: asymmetric upside from multiple expansion and steady cash returns; downside = option premium. Target total return +30–50% if core analytics growth and margin expansion persist; max loss = premium paid.
• Relative trade: long MCO / short NDAQ, dollar-neutral (1:1) for 6–18 months. Rationale: play relative exposure to credit issuance + analytics vs market infrastructure tied to equity trading; expect outperformance if credit markets remain active and data/ratings reprice. Risk: systematic sell-offs hurt both; set 12% stop on pair P/L.
• Income/neutral: buy MCO stock and sell 3–6 month covered calls to harvest option income (aim for 6–12% annualized). Rationale: monetizes low yield via option premium while retaining longer-term upside. Risk: upside capped to strike; downside protected only by premium—use for tactical yield enhancement.
• Tail hedge: buy 6–12 month MCO puts sized to 25% of gross long exposure. Rationale: cheap insurance against regulatory/litigation shocks that can erase multiples quickly. Cost should be budgeted as 1–2% of portfolio; preserves ability to add on weakness.